We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+5.18%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$2.1B
AUM Growth
-$29.1M
Cap. Flow
-$107M
Cap. Flow %
-5.12%
Top 10 Hldgs %
53.97%
Holding
31
New
4
Increased
1
Reduced
23
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 33.7%
2 Healthcare 23.29%
3 Consumer Discretionary 20.26%
4 Communication Services 18.25%
5 Technology 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
26
Starbucks
SBUX
$120B
$23.9M 1.14%
441,003
-27,370
-6% -$1.53M
LEN icon
27
Lennar Class A
LEN
$19.8B
$21.8M 1.04%
+540,242
New +$23.9M
SNI
28
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$15.9M 0.76%
+250,432
New +$16M
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$1.21M 0.06%
5,897
GILD icon
30
Gilead Sciences
GILD
$162B
-696,561
Closed -$58.1M
HRB icon
31
H&R Block
HRB
$5.58B
-28,296
Closed -$578K

Similar funds

Smead Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Smead Capital Management held 31 positions worth $2.1B, down 1.4% from $2.13B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Smead Capital Management withdrew a net $107M in Q3 2016, closing 2 positions and reducing 23 holdings. Its most notable exit was Gilead Sciences, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smead Capital Management opened a new position in Express Scripts Holding Company worth $30.3M.

  • Smead Capital Management's largest Q3 2016 buy was Express Scripts Holding Company: 428,982 shares worth $30.3M.
  • Smead Capital Management added most to Walt Disney in Q3 2016, an estimated $3.85M increase.
  • Smead Capital Management's biggest Q3 2016 reduction was Cabela's Inc, cutting an estimated $18.8M.
  • Smead Capital Management fully exited Gilead Sciences in Q3 2016, selling an estimated $58.1M.
  • Smead Capital Management's ten largest holdings make up 54% of its $2.1B portfolio in Q3 2016.
  • Smead Capital Management opened 4 new positions and closed 2 in Q3 2016.
  • Smead Capital Management's portfolio value fell 1.4% quarter-over-quarter to $2.1B.

Based on Smead Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.